Sirisha Jonnalagadda1, Jenny J Lin2, Judith E Nelson3, Charles A Powell4, John Salazar-Schicchi5, Andrew R Berman6, Steven M Keller7, Cardinale B Smith8, Linda Lurslurchachai2, Ethan A Halm9, Howard Leventhal10, Juan P Wisnivesky11. 1. University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, NJ. 2. Division of General Internal Medicine, New York, NY. 3. Division of Pulmonary, Critical Care and Sleep Medicine, New York, NY; Hertzberg Palliative Care Institute, Brookdale Department of Geriatrics and Palliative Medicine, The Mount Sinai Hospital, New York, NY. 4. Division of Pulmonary, Critical Care and Sleep Medicine, New York, NY. 5. Division of Pulmonary and Critical Care Medicine, Columbia University, New York, NY. 6. Division of Pulmonary and Critical Care Medicine, University of Medicine and Dentistry of New Jersey, Newark, NJ. 7. Department of Thoracic Surgery, Albert Einstein College of Medicine, Bronx, NY. 8. Division of Hematology and Oncology, Mount Sinai School of Medicine, New York, NY; Hertzberg Palliative Care Institute, Brookdale Department of Geriatrics and Palliative Medicine, The Mount Sinai Hospital, New York, NY. 9. Department of Medicine, University of Texas Southwestern, Dallas, TX. 10. Department of Psychology, Rutgers University, New Brunswick, NJ. 11. Division of General Internal Medicine, New York, NY; Division of Pulmonary, Critical Care and Sleep Medicine, New York, NY. Electronic address: juan.wisnivesky@mssm.edu.
Abstract
BACKGROUND: Disparities in lung cancer treatment and palliative care are well documented. However,the mechanisms underlying these disparities are not fully understood. In this study, we evaluated racial and ethnic differences in beliefs and attitudes about lung cancer treatment and palliative care among patients receiving a new diagnosis of lung cancer. METHODS: Patients were recruited from four medical centers in New York City and surveyed about their beliefs regarding lung cancer care, including disease-directed treatments, palliative and end-of-life care, and fatalistic and spiritual beliefs. We used univariate and multiple regression analyses to compare the distribution of beliefs among minority (black and Hispanic) and nonminority patients. RESULTS: Of the 335 patients, 21% were black, 20% were Hispanic, and 59% were nonminority. Beliefs about chemotherapy and radiotherapy were similar across the three groups ( P > .05),whereas black patients were more likely to believe that surgery might cause lung cancer to spread( P =.008). Fatalistic beliefs potentially affecting cancer treatment were more common among both minority groups ( P ≤ .02). No signifi cant differences were found in attitudes toward clinician communication about cancer prognosis ( P > .05). However, both blacks and Hispanics were more likely to have misconceptions about advance directives and hospice care ( P ≤ .02). CONCLUSIONS: Similarities and differences in beliefs about disease-directed treatment were observed between minority and nonminority patients with lung cancer. Minority patients hold more fatalistic views about the disease and misperceptions about advance care planning and hospice care. Further research is needed to assess the impact of these beliefs on decisions about lung cancer care and patient outcomes.
BACKGROUND: Disparities in lung cancer treatment and palliative care are well documented. However,the mechanisms underlying these disparities are not fully understood. In this study, we evaluated racial and ethnic differences in beliefs and attitudes about lung cancer treatment and palliative care among patients receiving a new diagnosis of lung cancer. METHODS:Patients were recruited from four medical centers in New York City and surveyed about their beliefs regarding lung cancer care, including disease-directed treatments, palliative and end-of-life care, and fatalistic and spiritual beliefs. We used univariate and multiple regression analyses to compare the distribution of beliefs among minority (black and Hispanic) and nonminority patients. RESULTS: Of the 335 patients, 21% were black, 20% were Hispanic, and 59% were nonminority. Beliefs about chemotherapy and radiotherapy were similar across the three groups ( P > .05),whereas black patients were more likely to believe that surgery might cause lung cancer to spread( P =.008). Fatalistic beliefs potentially affecting cancer treatment were more common among both minority groups ( P ≤ .02). No signifi cant differences were found in attitudes toward clinician communication about cancer prognosis ( P > .05). However, both blacks and Hispanics were more likely to have misconceptions about advance directives and hospice care ( P ≤ .02). CONCLUSIONS: Similarities and differences in beliefs about disease-directed treatment were observed between minority and nonminority patients with lung cancer. Minority patients hold more fatalistic views about the disease and misperceptions about advance care planning and hospice care. Further research is needed to assess the impact of these beliefs on decisions about lung cancer care and patient outcomes.
Authors: Tracy Balboni; Michael Balboni; M Elizabeth Paulk; Andrea Phelps; Alexi Wright; John Peteet; Susan Block; Chris Lathan; Tyler Vanderweele; Holly Prigerson Journal: Cancer Date: 2011-05-11 Impact factor: 6.860
Authors: Carmen R Green; Karen O Anderson; Tamara A Baker; Lisa C Campbell; Sheila Decker; Roger B Fillingim; Donna A Kalauokalani; Donna A Kaloukalani; Kathyrn E Lasch; Cynthia Myers; Raymond C Tait; Knox H Todd; April H Vallerand Journal: Pain Med Date: 2003-09 Impact factor: 3.750
Authors: Kendra L Schwartz; Heather Crossley-May; Fawn D Vigneau; Karl Brown; Mousumi Banerjee Journal: Cancer Causes Control Date: 2003-10 Impact factor: 2.506
Authors: Mitchell L Margolis; Jason D Christie; Gerard A Silvestri; Larry Kaiser; Silverio Santiago; John Hansen-Flaschen Journal: Ann Intern Med Date: 2003-10-07 Impact factor: 25.391
Authors: Devon K Check; Kathleen B Albers; Kanti M Uppal; Jennifer Marie Suga; Alyce S Adams; Laurel A Habel; Charles P Quesenberry; Lori C Sakoda Journal: Lung Cancer Date: 2018-09-11 Impact factor: 5.705
Authors: Christopher J Yarnell; Longdi Fu; Doug Manuel; Peter Tanuseputro; Therese Stukel; Ruxandra Pinto; Damon C Scales; Andreas Laupacis; Robert A Fowler Journal: JAMA Date: 2017-10-17 Impact factor: 56.272
Authors: Jenny J Lin; Grace Mhango; Melanie M Wall; Linda Lurslurchachai; Keosha T Bond; Judith E Nelson; Andrew R Berman; John Salazar-Schicchi; Charles Powell; Steven M Keller; Ethan A Halm; Howard Leventhal; Juan P Wisnivesky Journal: Ann Am Thorac Soc Date: 2014-05